MOTS-c, a mitochondrial-derived peptide, has garnered scientific interest due to its hypothesized role in cellular metabolism, stress adaptation, and physiological homeostasis. Studies suggest that ...
In 2010, after more than 10 years of basic research, Dr. Peter W. Schiller, a world-renowned peptide chemist and Director of the Chemical Biology and Peptide research unit at the Institut de ...
Researchers found a way to inhibit the mitochondrial fission in nerve cell axons, which can promote normal growth and potentially stop further damage in neurodegenerative disorders like hereditary ...
MENLO PARK, Calif., March 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and ...
Scientists have found that a protein tied to Alzheimer’s disease may actually strengthen the immune system’s fight against ...
Can humans really live to 150? In this video, Prof. Dato’ Sri Dr. Mike Chan of European Wellness Biomedical Group breaks down why organ transplants alone aren’t the answer and how cellular ...
Defects in mitochondria, the cell’s energy factories, can play a part in cancer, diabetes, and other ailments. A Canadian research team has developed peptide-based biochemical tools that traverse the ...
The F0F1 ATP synthase is a large, multi-subunit complex expressed in the mitochondrial inner membrane, where it uses the energy from oxidative phosphorylation to generate ATP. Surprisingly, this ...
Malate dehydrogenase isoenzymes catalyzing the oxidation of malate to oxaloacetate are highly active enzymes in mitochondria, in peroxisomes, in chloroplasts, and in the cytosol. Determination of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results